The impact is already hitting science agencies hard. The NIH—the world's largest public biomedical research funder—has had to rely on leftover stopgap funds.
New grant awards have slowed to a trickle — exacerbating the effects of a record-long shutdown in October.
(h/t @jeremymberg.bsky.social)
